Recently, therapy to reduce PCSK9 activity has been approved for use in those with cardiovascular disease who require additional LDL-C lowering despite the use of maximally tolerated statins.
New research investigates how controlling blood pressure, cholesterol, and HbA1c in patients with diabetes affects their risk of developing heart disease.
The effects of treatment with continuous positive airway pressure on glycemic control in patients with type 2 diabetes and obstructive sleep apnea were evaluated in a recent study.